Charles Schwab Investment Management Inc. Grows Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Charles Schwab Investment Management Inc. boosted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 43.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 938,187 shares of the company’s stock after purchasing an additional 286,380 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.36% of Ryan Specialty worth $62,286,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of RYAN. Hollencrest Capital Management acquired a new position in shares of Ryan Specialty during the third quarter worth $25,000. Assetmark Inc. purchased a new position in shares of Ryan Specialty in the 3rd quarter valued at about $34,000. GAMMA Investing LLC raised its position in shares of Ryan Specialty by 96.4% during the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after acquiring an additional 297 shares in the last quarter. Crewe Advisors LLC purchased a new stake in Ryan Specialty during the second quarter worth approximately $39,000. Finally, Rothschild Investment LLC acquired a new position in Ryan Specialty in the second quarter valued at approximately $87,000. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on RYAN. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. UBS Group raised their price objective on Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a report on Tuesday, August 13th. The Goldman Sachs Group lifted their target price on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Barclays upped their target price on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Finally, Wells Fargo & Company lifted their price target on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $71.67.

Ryan Specialty Trading Up 0.4 %

NYSE:RYAN opened at $75.40 on Friday. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.97. The business’s 50-day moving average is $69.99 and its two-hundred day moving average is $63.12. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $19.74 billion, a PE ratio of 97.92, a price-to-earnings-growth ratio of 1.70 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. The firm had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty’s revenue for the quarter was up 20.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 EPS. Research analysts predict that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were issued a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s payout ratio is 57.14%.

Insider Buying and Selling

In related news, Director David P. Bolger sold 7,055 shares of the company’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company’s stock, valued at $5,539,201.12. This represents a 8.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by insiders.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.